Artwork

Content provided by Slice of Healthcare LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Slice of Healthcare LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

#438 - Cody Simmons, CEO at DermaSensor

18:48
 
Share
 

Manage episode 408766931 series 2294118
Content provided by Slice of Healthcare LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Slice of Healthcare LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Join us on the latest episode, hosted by Jared S. Taylor! Our Guest: Abhinav Shashank, Cody Simmons, CEO at DermaSensor.

What you’ll get out of this episode:

  • Cody Simmons' Background: Cody discusses his journey from a biomaterials lab at Stanford and roles at Genentech, leading to his involvement with DermaSensor, a health tech startup.
  • DermaSensor's Evolution: Founded in 2009, DermaSensor was initially a research-focused virtual startup. Cody joined in 2016, transforming it into a fully-fledged company, leading to the recent FDA clearance.
  • FDA Clearance Milestone: DermaSensor's device, which has transitioned from a 30-pound machine to a portable size, received FDA clearance, marking a significant achievement for the company and a relief for the team.
  • Impact on Primary Care: The device provides primary care physicians (PCPs) with dermatologist-level skin cancer triage capabilities, addressing a longstanding need for improved skin cancer assessment tools in primary care.
  • Use of AI in DermaSensor: DermaSensor employs AI for lesion assessment, using a locked algorithm to ensure accuracy and adherence to FDA requirements. The technology allows for a standardized analysis, offering a real-time quantitative result for skin cancer risk.

To learn more about DermaSensor:
Website: https://www.dermasensor.com/
LinkedIn: https://www.linkedin.com/company/dermasensor/

Guest's Socials:
LinkedIn: https://www.linkedin.com/in/codyvsimmons/

Our sponsors for this episode are:
Sage Growth Partners https://www.sage-growth.com/
Quantum Health https://www.quantum-health.com/

Show and Host's Socials:
Slice of Healthcare
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Jared S Taylor
LinkedIn: https://www.linkedin.com/in/jaredstaylor/

WHAT IS SLICE OF HEALTHCARE?
The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

  continue reading

459 episodes

Artwork
iconShare
 
Manage episode 408766931 series 2294118
Content provided by Slice of Healthcare LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Slice of Healthcare LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Join us on the latest episode, hosted by Jared S. Taylor! Our Guest: Abhinav Shashank, Cody Simmons, CEO at DermaSensor.

What you’ll get out of this episode:

  • Cody Simmons' Background: Cody discusses his journey from a biomaterials lab at Stanford and roles at Genentech, leading to his involvement with DermaSensor, a health tech startup.
  • DermaSensor's Evolution: Founded in 2009, DermaSensor was initially a research-focused virtual startup. Cody joined in 2016, transforming it into a fully-fledged company, leading to the recent FDA clearance.
  • FDA Clearance Milestone: DermaSensor's device, which has transitioned from a 30-pound machine to a portable size, received FDA clearance, marking a significant achievement for the company and a relief for the team.
  • Impact on Primary Care: The device provides primary care physicians (PCPs) with dermatologist-level skin cancer triage capabilities, addressing a longstanding need for improved skin cancer assessment tools in primary care.
  • Use of AI in DermaSensor: DermaSensor employs AI for lesion assessment, using a locked algorithm to ensure accuracy and adherence to FDA requirements. The technology allows for a standardized analysis, offering a real-time quantitative result for skin cancer risk.

To learn more about DermaSensor:
Website: https://www.dermasensor.com/
LinkedIn: https://www.linkedin.com/company/dermasensor/

Guest's Socials:
LinkedIn: https://www.linkedin.com/in/codyvsimmons/

Our sponsors for this episode are:
Sage Growth Partners https://www.sage-growth.com/
Quantum Health https://www.quantum-health.com/

Show and Host's Socials:
Slice of Healthcare
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Jared S Taylor
LinkedIn: https://www.linkedin.com/in/jaredstaylor/

WHAT IS SLICE OF HEALTHCARE?
The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

  continue reading

459 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide